# Real-world Ruxolitinib Experience in PV

> **NCT06251102** · — · NOT_YET_RECRUITING · sponsor: **Gruppo Italiano Malattie EMatologiche dell'Adulto** · enrollment: 153 (estimated)

## Conditions studied

- Polycythemia Vera

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06251102
- **Lead sponsor:** Gruppo Italiano Malattie EMatologiche dell'Adulto
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-07
- **Primary completion:** 2025-07
- **Final completion:** 2025-07
- **Target enrollment:** 153 (ESTIMATED)
- **Last updated:** 2024-05-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06251102

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06251102, "Real-world Ruxolitinib Experience in PV". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06251102. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*